PULSE trial
Research type
Research Study
Full title
PUlsecath mechanicaL Support Evaluation
IRAS ID
213934
Contact name
Simon Redwood
Contact email
Sponsor organisation
Thoraxcentrum, Erasmus Medical Centre, Rotterdam
Duration of Study in the UK
1 years, 6 months, 30 days
Research summary
This study aims to investigate the effects of PulseCath iVAC2L on the heart and the circulatory system. The cardiac muscle can become weakened and overloaded, leading to symptoms of heart failure. Heart support devices are utilized to prevent additional damage to, or instability of the heart and to reduce the occurrence of potentially fatal complications during angioplasty. Before, during and after angioplasty with PulseCath iVAC2L support, working patterns of the heart pump will be monitored invasively. Additionally, measurements reflecting the behaviour of the circulatory system will be also obtained, including additional data from extra blood samples.
REC name
London - Bloomsbury Research Ethics Committee
REC reference
17/LO/1990
Date of REC Opinion
4 Jan 2018
REC opinion
Further Information Favourable Opinion